3
|
Siccha SM, Cueto AM, Parrón-Pajares M, González-Morán G, Pacio-Miguez M, Del Pozo Á, Solís M, Rodriguez-Jimenez C, Caino S, Fano V, Heath KE, García-Miñaúr S, Palomares-Bralo M, Santos-Simarro F. Delineation of the clinical and radiological features of Stuve-Wiedemann syndrome childhood survivors, four new cases and review of the literature. Am J Med Genet A 2020; 185:856-865. [PMID: 33305909 DOI: 10.1002/ajmg.a.62010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Revised: 09/08/2020] [Accepted: 11/14/2020] [Indexed: 11/07/2022]
Abstract
Stuve-Wiedemann syndrome (SWS; MIM 601559) is a rare autosomal recessive disease caused by mutations in the leukemia inhibitor factor receptor gene (LIFR). Common clinical and radiological findings are often observed, and high neonatal mortality occurs due to respiratory distress and hyperthermic episodes. Despite initially considered as a lethal disorder during the newborn period, in recent years, several SWS childhood survivors have been reported. We report a detailed clinical and radiological characterization of four unrelated childhood SWS molecularly confirmed patients and review 22 previously reported childhood surviving cases. We contribute to the definition of the childhood survival phenotype of SWS, emphasizing the evolving phenotype, characterized by skeletal abnormalities with typical radiological findings, distinctive dysmorphic features, and dysautonomia. Based on the typical features and clinical course, early diagnosis is possible and crucial to plan appropriate management and prevent potential complications. Genetic confirmation is advisable in order to improve genetic counseling to the patients and their families.
Collapse
Affiliation(s)
- Sofía M Siccha
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,Department of Pediatrics, Hospital Universitario la Paz, Madrid, Spain
| | - Anna María Cueto
- Department of Clinical and Molecular Genetics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.,Medical Genetics Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.,European Reference Network, ERN CRANIO, Barcelona, Spain
| | - Manuel Parrón-Pajares
- Department of Radiology, Hospital Universitario La Paz, Madrid, Spain.,Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain
| | - Gaspar González-Morán
- Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Department of Orthopaedic Surgery and Traumatology, Hospital Universitario la Paz, Madrid, Spain
| | - Marta Pacio-Miguez
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain
| | - Ángela Del Pozo
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Mario Solís
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Carmen Rodriguez-Jimenez
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain
| | - Silvia Caino
- Growth and Developmental Department Hospital de Pediatría Garrahan, Buenos Aires, Argentina
| | - Virginia Fano
- Growth and Developmental Department Hospital de Pediatría Garrahan, Buenos Aires, Argentina
| | - Karen E Heath
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Sixto García-Miñaúr
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - María Palomares-Bralo
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| | - Fernando Santos-Simarro
- Institute of Medical & Molecular Genetics (INGEMM), Hospital Universitario La Paz, Universidad Autónoma de Madrid, IdiPAZ, Madrid, Spain.,Skeletal Dysplasia Multidisciplinary Unit (UMDE) and ERN BOND, Hospital Universitario La Paz, Madrid, Spain.,European Reference Network, ERN ITHACA, Madrid, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, U753), Instituto Carlos III, Madrid, Spain
| |
Collapse
|
10
|
Dagoneau N, Scheffer D, Huber C, Al-Gazali LI, Di Rocco M, Godard A, Martinovic J, Raas-Rothschild A, Sigaudy S, Unger S, Nicole S, Fontaine B, Taupin JL, Moreau JF, Superti-Furga A, Le Merrer M, Bonaventure J, Munnich A, Legeai-Mallet L, Cormier-Daire V. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am J Hum Genet 2004; 74:298-305. [PMID: 14740318 PMCID: PMC1181927 DOI: 10.1086/381715] [Citation(s) in RCA: 128] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2003] [Accepted: 11/11/2003] [Indexed: 11/03/2022] Open
Abstract
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality. Clinical overlap with Schwartz-Jampel type 2 syndrome (SJS2) has suggested that SWS and SJS2 could be allelic disorders. Through studying a series of 19 families with SWS/SJS2, we have mapped the disease gene to chromosome 5p13.1 at locus D5S418 (Zmax=10.66 at theta =0) and have identified null mutations in the leukemia inhibitory factor receptor (LIFR or gp190 chain) gene. A total of 14 distinct mutations were identified in the 19 families. An identical frameshift insertion (653_654insT) was identified in families from the United Arab Emirates, suggesting a founder effect in that region. It is interesting that 12/14 mutations predicted premature termination of translation. Functional studies indicated that these mutations alter the stability of LIFR messenger RNA transcripts, resulting in the absence of the LIFR protein and in the impairment of the JAK/STAT3 signaling pathway in patient cells. We conclude, therefore, that SWS and SJS2 represent a single clinically and genetically homogeneous condition due to null mutations in the LIFR gene on chromosome 5p13.
Collapse
Affiliation(s)
- Nathalie Dagoneau
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Deborah Scheffer
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Céline Huber
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Lihadh I. Al-Gazali
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Maja Di Rocco
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Anne Godard
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jelena Martinovic
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Annick Raas-Rothschild
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Sabine Sigaudy
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Sheila Unger
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Sophie Nicole
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Bertrand Fontaine
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jean-Luc Taupin
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jean-François Moreau
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Andrea Superti-Furga
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Martine Le Merrer
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Jacky Bonaventure
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Arnold Munnich
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Laurence Legeai-Mallet
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| | - Valérie Cormier-Daire
- Department of Medical Genetics and INSERM U393, Hôpital Necker-Enfants Malades, and INSERM U546, Faculté de Médecine Pitié-Salpêtrière, Paris; Department of Paediatrics, Faculty of Medicine and Health Sciences, United Arab Emirates University, Al Ain; Second Unit of Pediatrics, Istituto G. Gaslini, Genoa; INSERM U463, Institut de Biologie, Nantes, France; Department of Genetics, Hadassah University Medical Center, Jerusalem; Hôpital d’Enfants de La Timone, Marseille; Division of Clinical and Genetic Metabolics, University of Toronto, Toronto; CNRS UMR 5540, Université Bordeaux 2, Bordeaux; and Department of Pediatrics, University of Lausanne, Lausanne
| |
Collapse
|